Thorlacius-Ussing, Louise
Brooks, Patrick Terrence
Nielsen, Henrik
Jensen, Bitten Aagaard
Wiese, Lothar
Sækmose, Susanne Gjørup
Johnsen, Stine
Gybel-Brask, Mikkel
Johansen, Isik S.
Bruun, Mie Topholm
Stærke, Nina Breinholdt
Østergaard, Lars
Erikstrup, Christian
Ostrowski, Sisse Rye
Homburg, Keld Mikkelsen
Georgsen, Jørgen
Mikkelsen, Susan
Sandholdt, Håkon
Leding, Cæcilie
Hovmand, Nichlas
Clausen, Clara Lundetoft
Tinggaard, Michaela
Pedersen, Karen Brorup Heje
Iversen, Katrine Kjær
Tingsgård, Sandra
Israelsen, Simone Bastrup
Benfield, Thomas
Funding for this research was provided by:
Lundbeckfonden
Article History
Received: 24 January 2022
Accepted: 31 August 2022
First Online: 30 September 2022
Competing interests
: Dr Nielsen declares grants from Novo Nordisk Foundation and personal fees from GSK and MDS outside of the submitted work. Dr Østergaard reports personal fees from Sanofi. Dr Erikstrup reports grants from Abbots diagnostic outside of the submitted work. Dr Benfield reports grants from Novo Nordisk Foundation, grants from Simonsen Foundation, grants and personal fees from GSK, grants and personal fees from Pfizer, personal fees from Boehringer Ingelheim, personal fees from Abbvie, grants and personal fees from Gilead, personal fees from MSD, grants from Lundbeck Foundation, grants from Kai Hansen Foundation, and grants from Erik and Susanna Olsen’s Charitable Fund outside the submitted work. All other authors have nothing to disclose.